| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |